Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population.

Huerta C, Varas-Lorenzo C, Castellsague J, García Rodríguez LA.

Heart. 2006 Nov;92(11):1610-5.

PMID:
16717069
2.

Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population.

Huerta C, Castellsague J, Varas-Lorenzo C, García Rodríguez LA.

Am J Kidney Dis. 2005 Mar;45(3):531-9.

PMID:
15754275
3.

Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study.

Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel TA.

Lancet. 2004 May 29;363(9423):1751-6.

PMID:
15172772
4.
5.

[Association between non-steroid antiinflammatory drugs intake and decompensation of heart failure].

Laredo L, Rodríguez A, Vargas E, Moreno A, Cruz A, García Jde D.

Med Clin (Barc). 2003 May 10;120(17):658-60. Spanish.

PMID:
12747814
6.

Nonsteroidal antiinflammatory drugs as a trigger of clinical heart failure.

García Rodríguez LA, Hernández-Díaz S.

Epidemiology. 2003 Mar;14(2):240-6.

PMID:
12606892
7.

Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.

McGettigan P, Han P, Jones L, Whitaker D, Henry D.

Br J Clin Pharmacol. 2008 Jun;65(6):927-34. doi: 10.1111/j.1365-2125.2008.03121.x.

PMID:
18384446
8.

Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis.

Ungprasert P, Srivali N, Kittanamongkolchai W.

Eur J Intern Med. 2015 Nov;26(9):685-90. doi: 10.1016/j.ejim.2015.09.012. Review.

PMID:
26427540
9.

Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study.

Feenstra J, Heerdink ER, Grobbee DE, Stricker BH.

Arch Intern Med. 2002 Feb 11;162(3):265-70.

PMID:
11822918
10.

Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.

Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.

Arch Intern Med. 2005 May 9;165(9):978-84.

PMID:
15883235
11.

NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics.

Heerdink ER, Leufkens HG, Herings RM, Ottervanger JP, Stricker BH, Bakker A.

Arch Intern Med. 1998 May 25;158(10):1108-12.

PMID:
9605782
12.

Increased mortality and cardiovascular morbidity associated with use of nonsteroidal anti-inflammatory drugs in chronic heart failure.

Gislason GH, Rasmussen JN, Abildstrom SZ, Schramm TK, Hansen ML, Fosbøl EL, Sørensen R, Folke F, Buch P, Gadsbøll N, Rasmussen S, Poulsen HE, Køber L, Madsen M, Torp-Pedersen C.

Arch Intern Med. 2009 Jan 26;169(2):141-9. doi: 10.1001/archinternmed.2008.525.

PMID:
19171810
13.

Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors.

Bouvy ML, Heerdink ER, Hoes AW, Leufkens HG.

Drug Saf. 2003;26(13):983-9.

PMID:
14583072
14.

Analgesic, antiulcer, antithrombotic drugs and organ damage: a population-based case-control study.

Battelli D, Riccardi R, Piscaglia AC, Stefanelli ML, Mussoni L, Zani A, Vitale V, Monachese N.

Minerva Med. 2015 Dec;106(6):323-31.

PMID:
26787649
16.

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study.

Schmidt M, Christiansen CF, Mehnert F, Rothman KJ, Sørensen HT.

BMJ. 2011 Jul 4;343:d3450. doi: 10.1136/bmj.d3450.

PMID:
21727167
17.

Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population.

Merlo J, Broms K, Lindblad U, Björck-Linné A, Liedholm H, Ostergren PO, Erhardt L, Råstam L, Melander A.

Eur J Clin Pharmacol. 2001 Apr;57(1):71-5.

PMID:
11372596
18.

Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.

Arfè A, Scotti L, Varas-Lorenzo C, Nicotra F, Zambon A, Kollhorst B, Schink T, Garbe E, Herings R, Straatman H, Schade R, Villa M, Lucchi S, Valkhoff V, Romio S, Thiessard F, Schuemie M, Pariente A, Sturkenboom M, Corrao G; Safety of Non-steroidal Anti-inflammatory Drugs (SOS) Project Consortium..

BMJ. 2016 Sep 28;354:i4857. doi: 10.1136/bmj.i4857.

PMID:
27682515
19.

Adverse drug reaction-related hospitalisations among patients with heart failure at two hospitals in the United Arab Emirates.

Saheb Sharif-Askari N, Syed Sulaiman SA, Saheb Sharif-Askari F, Hussain AA.

Int J Clin Pharm. 2015 Feb;37(1):105-12. doi: 10.1007/s11096-014-0046-3.

PMID:
25488317
20.

Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure.

Pérez Gutthann S, García Rodríguez LA, Raiford DS, Duque Oliart A, Ris Romeu J.

Arch Intern Med. 1996 Nov 25;156(21):2433-9.

PMID:
8944736
Items per page

Supplemental Content

Support Center